Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice

Xinhui Liu, Liwen Gao, Xi Huang, Ruyu Deng, Shanshan Wu, Yu Peng, Jiandong LuFrontiers in Pharmacology 2023 · DOI

Abstract: Acute kidney injury (AKI) induced by cisplatin is a major clinical challenge. This study investigates the protective effects of Huangqi-Danshen decoction (HDD), a traditional Chinese herbal formula, against cisplatin-induced AKI. Using a mouse model and advanced metabolomics, researchers found that HDD significantly reduces renal damage by restoring NAD+ biosynthesis, thereby suppressing apoptosis, inflammation, and oxidative stress.

Introduction

Cisplatin is a highly effective chemotherapy agent used for various solid tumors. However, its clinical utility is severely limited by nephrotoxicity, with approximately one-third of patients developing Acute Kidney Injury (AKI). While Huangqi-Danshen decoction (HDD)—a mixture of Astragalus membranaceus and Salvia miltiorrhiza—has shown promise in chronic kidney disease, its efficacy against acute cisplatin-induced hits remained unexplored until now.

Methods

The researchers established an AKI model by injecting C57BL/6 mice with a single high dose of cisplatin (20 mg/kg). The treatment group received HDD (6.8 g/kg/d) for five consecutive days prior to the cisplatin challenge. The study utilized a multi-pronged analytical approach, including biochemical detection of Serum Creatinine (Scr) and Blood Urea Nitrogen (BUN), histopathological evaluation, and Western blot analysis for injury markers. Crucially, non-target metabolomics via UHPLC-QTOF/MS was employed to map the metabolic shifts in renal tissues.

Key Results

Functional and Structural Protection

HDD treatment demonstrated a robust protective effect on kidney function and structure. Mice treated with HDD showed significantly lower levels of Scr and BUN compared to the cisplatin-only group. Histologically, HDD markedly reduced tubular necrosis, dilation, and overall injury scores.

HDD treatment significantly reduces tubular injury and histological damage in cisplatin-induced AKI mice.

Molecular Markers and Apoptosis

Beyond physical structure, HDD suppressed molecular markers of damage. The expression of Neutrophil Gelatinase-Associated Lipocalin (NGAL), a sensitive biomarker for renal injury, was significantly downregulated in the HDD-treated group. Furthermore, HDD inhibited apoptosis by suppressing pro-apoptotic proteins such as Bax, cleaved caspase-3, and p53.

Western blot and quantitative analysis of NGAL expression, showing HDD-mediated suppression of this kidney injury marker.

The NAD+ Metabolic Rescue

The study's centerpiece was the discovery of a metabolic "rescue" operation. Metabolomics identified 165 metabolites restored by HDD, with pathway analysis pointing directly to nicotinate and nicotinamide metabolism. Cisplatin causes a massive drop in Nicotinamide Adenine Dinucleotide (NAD+), essential for cellular energy and repair. HDD was found to upregulate three critical enzymes—NAMPT, QPRT, and NMNAT1—to replenish renal NAD+ levels and protect the cells from oxidative stress.

Conclusion

In summary, Huangqi-Danshen decoction exerts a significant protective effect against cisplatin-induced AKI. By modulating NAD+ biosynthesis and suppressing the downstream cascades of inflammation and apoptosis, HDD offers a potential therapeutic strategy to mitigate the side effects of cisplatin chemotherapy. Future research will focus on identifying the specific active compounds within the decoction and exploring its potential as a rescue therapy after the onset of injury.

Summary updated

Abstract

<b>Background:</b> Acute kidney injury (AKI) induced by cisplatin remains a major impediment to the clinical application of cisplatin, necessitating urgent exploration for promising solutions. Huangqi-Danshen decoction (HDD), a Chinese herbal preparation, has been shown by our group to have a reno-protective effect in adenine-induced chronic kidney disease mice and diabetic <i>db/db</i> mice. However, the effect of HDD on cisplatin-induced AKI and its underlying mechanisms are unknown. <b>Methods:</b> The AKI model was established by intraperitoneal injection of cisplatin (20 mg/kg) in C57BL/6 mice. The mice in the treatment group were administrated with HDD (6.8 g/kg/d) for 5 consecutive days before cisplatin challenge. After 72 h cisplatin injection, blood and kidney tissue were subsequently collected for biochemical detection, histopathological evaluation, Western blot analysis, immunohistochemical staining, and terminal deoxynucleotidyl transferase (TdT)-mediated dUTP nick end labeling assay. Ultra-high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry was used to detect changes in renal metabolites. <b>Results:</b> The results showed that HDD significantly reduced serum creatinine and blood urea nitrogen levels and alleviated renal histopathological injury in cisplatin-induced AKI mice. And HDD treatment demonstrated a significant inhibition in apoptosis, inflammation, and oxidative stress in AKI mice. Moreover, non-target metabolomics revealed that HDD significantly restored 165 altered metabolites in AKI mice. Subsequent enrichment analysis and pathway analysis of these metabolites indicated that nicotinate and nicotinamide metabolism was the primary pathway affected by HDD intervention. Further investigation showed that HDD could upregulate nicotinamide adenine dinucleotide (NAD<sup>+</sup>) biosynthesis-related enzymes quinolinate phosphoribosyltransferase, nicotinamide mononucleotide adenylyltransferase 1, and nicotinamide phosphoribosyltransferase to replenish NAD<sup>+</sup> content in the kidney of AKI mice. <b>Conclusion:</b> In summary, HDD exerted a protective effect against cisplatin-induced AKI and suppressed apoptosis, inflammation, and oxidative stress in the kidney of AKI mice, which may be attributed to the modulation of NAD<sup>+</sup> biosynthesis.
BibTeX
@inproceedings{liu2023huangqi,
  author = {Xinhui Liu and Liwen Gao and Xi Huang and Ruyu Deng and Shanshan Wu and Yu Peng and Jiandong Lu},
  title = {{Huangqi-Danshen decoction protects against cisplatin-induced acute kidney injury in mice}},
  booktitle = {Frontiers in Pharmacology},
  year = {2023},
  doi = {10.3389/fphar.2023.1236820},
}
Figure